Trial Profile
A Phase 1 Study in Healthy Volunteers to Evaluate UDP glucuronosyl transferase (UGT) and Cytochrome (CYP) P450 - Mediated Drug-Drug Interactions Between GS-9688 and Probe Drugs
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Selgantolimod (Primary) ; Ciprofloxacin; Probenecid; Rifampicin; Voriconazole
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 16 Mar 2019 Results of two healthy volunteer studies (n=144) including this study, assessing impact of inhibition or induction on GS- 9688 pharmakokinetics, were presented at the 120th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 09 Jul 2018 Status changed from not yet recruiting to completed.
- 17 May 2017 New trial record